The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Open accessPublished version of a preprint
Abstract
A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world 1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor 4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses 1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This amino acid sequence extends from residue Thr333 to residue Gly526 [28].”
From Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells (2022) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [7]
In the citing paper
“When binding to hACE2, spike amino acid F486 interacts with hACE2 residues L79, M82 and Y83, which collectively comprise a hotspot for ACE2 differences between mammalian species13.”
From Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationPhaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationMartínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961
Cited by
Sorted by citations
Items 201–300 of 1,026
COVID-19 and metabolic disease: mechanisms and clinical management
Steenblock, C., Schwarz, P. E. H., Ludwig, B., Linkermann, A., Zimmet, P., Kulebyakin, K. Y., Va, T., Markov, A. G., Lehnert, H., de Angelis, M. H., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00244-8 · Cited by 256
Islam, M. S., Aziz, M. A., Aziz, M. A., Aka, T. D., & Jakaria, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05684 · Cited by 253
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Hager, K. J., Marc, G. P., Gobeil, P., Diaz, R. S., Heizer, G., Llapur, C. J., Makarkov, A. I., Vasconcellos, E., Pillet, S., Riera, F. O., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2201300 · Cited by 253
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Kemp, S. A., Meng, B., Ferriera, I. A., Datir, R., Harvey, W. T., Papa, G., Lytras, S., Collier, D. A., Mohamed, A., Gallo, G., et al. (2020) · doi:10.1101/2020.12.14.422555 · Cited by 252
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Glasgow, A., Glasgow, J., Limonta, D., Solomon, P., Lui, I., Zhang, Y., Nix, M. A., Rettko, N. J., Zha, S., Yamin, R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016093117 · Cited by 251
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., Marco, A. D., di Iulio, J., et al. (2021) · Nature · doi:10.1038/d41586-021-03825-4 · Cited by 251
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Zhang, Q., Chen, C. Z., Swaroop, M., Xu, M., Wang, L., Lee, J., Wang, A. Q., Pradhan, M., Hagen, N. R., Chen, L., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00222-5 · Cited by 249
Self-citationDeng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-González, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., et al. (2021) · doi:10.1101/2021.03.07.21252647 · Cited by 651
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 247
Liu, Y., Hu, G., Wang, Y., Ren, W., Zhao, X., Ji, F., Zhu, Y., Feng, F., Gong, M., Ju, X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025373118 · Cited by 247
Self-citationSARS-CoV-2 spreads through cell-to-cell transmission
Zeng, C., Evans, J. P., King, T., Zheng, Y.-M., Oltz, E. M., Whelan, S. P. J., Saif, L. J., Peeples, M. E., & Liu, S.-L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111400119 · Cited by 246
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
Gussow, A. B., Auslander, N., Faure, G., Wolf, Y. I., Zhang, F., & Koonin, E. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008176117 · Cited by 245
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Hwang, Y., Lu, R., Su, S.-C., Chiang, P.-Y., Ko, S.-H., Ke, F.-Y., Liang, K.-H., Hsieh, T.-Y., & Wu, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-021-00784-w · Cited by 247
Greaney, A. J., Loes, A. N., Gentles, L. E., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi9915 · Cited by 244
Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors
Pinals, R. L., Ledesma, F., Yang, D., Navarro, N., Jeong, S., Pak, J. E., Kuo, L., Chuang, Y., Cheng, Y., Sun, H.-Y., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00118 · Cited by 241
Wang, R., Zhang, Q., Ge, J., Ren, W., Zhang, R., Lan, J., Ju, B., Su, B., Yu, F., Chen, P., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.003 · Cited by 240
Self-citationDetecting the Coronavirus (COVID-19)
Pokhrel, P., Hu, C., & Mao, H. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01153 · Cited by 240
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
Ahmed, M. H., & Hassan, A. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00610-8 · Cited by 239
Benussi, A., Pilotto, A., Premi, E., Libri, I., Giunta, M., Agosti, C., Alberici, A., Baldelli, E., Benini, M., Bonacina, S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009848 · Cited by 238
Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
Ali, A., & Vijayan, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-71188-3 · Cited by 238
Du, S., Cao, Y., Zhu, Q., Yü, P., Qi, F., Wang, G., Du, X., Bao, L., Deng, W., Zhu, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.035 · Cited by 238
Self-citationWu, W., Cheng, Y., Zhou, H. W., Sun, C., & Zhang, S. (2023) · Virology Journal · doi:10.1186/s12985-023-01968-6 · Cited by 234
Self-citationSARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
Wérion, A., Belkhir, L., Perrot, M., Schmit, G., Aydın, S., Chen, Z., Penaloza, A., Greef, J. D., Yıldız, H., Pothen, L., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.019 · Cited by 233
Aptamer Blocking Strategy Inhibits SARS‐CoV‐2 Virus Infection
Sun, M., Liu, S., Wei, X., Wan, S., Huang, M., Song, T., Lu, Y. W. W., Weng, X., Zhu, L., Chen, H., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202100225 · Cited by 232
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
Xu, J., Xu, K. Y., Jung, S., Conte, A., Lieberman, J. A., Muecksch, F., Lorenzi, J. C. C., Park, S., Schmidt, F., Wang, Z., et al. (2021) · Nature · doi:10.1038/s41586-021-03676-z · Cited by 232
Salazar, E., Christensen, P. A., Graviss, E. A., Nguyen, D. T., Castillo, B., Chen, J., Lopez, B. V., Eagar, T. N., Yi, X., Zhao, P., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.001 · Cited by 231
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Khateeb, J., Li, Y., & Zhang, H. (2021) · Critical Care · doi:10.1186/s13054-021-03662-x · Cited by 231
Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane
Woo, H., Park, S., Choi, Y. K., Park, T., Tanveer, M., Cao, Y., Kern, N. R., Lee, J., Yeom, M. S., Croll, T. I., et al. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c04553 · Cited by 230
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y., Pinto, D., Walls, A. C., Liu, Z., Marco, A. D., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., et al. (2022) · Science · doi:10.1126/science.adc9127 · Cited by 230
Sun, L., Li, P., Ju, X., Rao, J. Y., Huang, W., Ren, L., Zhang, S., Xiong, T., Xu, K., Zhou, X., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.008 · Cited by 229
Self-citationCellular host factors for SARS-CoV-2 infection
Baggen, J., Vanstreels, E., Jansen, S., & Daelemans, D. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00958-0 · Cited by 227
Kang, Y.-F., Sun, C., Zhuang, Z., Yuan, R.-Y., Zheng, Q., Li, J.-P., Zhou, P., Chen, X.-C., Liu, Z., Zhang, X., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c08379 · Cited by 226
The glycosylation in SARS-CoV-2 and its receptor ACE2
Gong, Y., Qin, S., Dai, L., & Tian, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00809-8 · Cited by 226
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Yu, L., Zhang, Z., Li, Y., Lian, X., Xie, Y., Li, S., Xin, S., Cao, P., & Lu, J. (2020) · iScience · doi:10.1016/j.isci.2020.101400 · Cited by 224
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
Sanders, D. W., Jumper, C. C., Ackerman, P. J., Bracha, D., Donlic, A., Kim, H., Kenney, D., Castello-Serrano, I., Suzuki, S., Tamura, T., et al. (2021) · eLife · doi:10.7554/elife.65962 · Cited by 224
Ding, S., & Liang, T. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.052 · Cited by 223
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Sternberg, A., & Naujokat, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118056 · Cited by 223
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Cai, Y., Zhang, J., Xiao, T., Lavine, C. L., Rawson, S., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A. K., et al. (2021) · Science · doi:10.1126/science.abi9745 · Cited by 222
Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
Lupala, C. S., Ye, Y., Chen, H., Su, X., & Liu, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.079 · Cited by 222
The effect of spike mutations on SARS-CoV-2 neutralization
Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J. L., Thomas, P., Graham, C., Seow, J., Lee, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108890 · Cited by 221
Impact of the delta variant on vaccine efficacy and response strategies
Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., Mao, Q., Xu, M., & Liang, Z. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1976153 · Cited by 219
Self-citationCOVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C. A., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 219
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
Mariano, G., Farthing, R. J., Lale-Farjat, S. L. M., & Bergeron, J. R. C. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.605236 · Cited by 219
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Yu, L., Zhang, Z., Li, Y., Lian, X., Xie, Y., Li, S., Xin, S., Cao, P., & Lu, J. (2020) · iScience · doi:10.1016/j.isci.2020.101160 · Cited by 218
Izquierdo-Lara, R. W., Elsinga, G., Heijnen, L., Munnink, B. B. O., Schapendonk, C. M. E., Nieuwenhuijse, D. F., Kon, M., Lu, L., Aarestrup, F. M., Lycett, S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2705.204410 · Cited by 217
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Linsky, T. W., Vergara, R., Codina, N., Nelson, J. W., Walker, M. J., Su, W., Barnes, C. O., Hsiang, T.-Y., Esser-Nobis, K., Yu, K., et al. (2020) · Science · doi:10.1126/science.abe0075 · Cited by 216
Salazar, E., Kuchipudi, S. V., Christensen, P. A., Eagar, T. N., Yi, X., Zhao, P., Jin, Z., Long, S. W., Olsen, R. J., Chen, J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141206 · Cited by 216
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Chavda, V. P., Vora, L. K., Pandya, A., & Patravale, V. B. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.021 · Cited by 216
Autopsy findings in COVID-19-related deaths: a literature review
Maiese, A., Manetti, A. C., Russa, R. L., Paolo, M. D., Turillazzi, E., Frati, P., & Fineschi, V. (2020) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-020-00310-8 · Cited by 212
Yen, H., Sit, T. H. C., Brackman, C. J., Chuk, S. S., Gu, H., Tam, K. W. S., Law, P. Y.-T., Leung, G. M., Peiris, M., Poon, L. L. M., et al. (2022) · SSRN Electronic Journal · doi:10.1016/s0140-6736(22)00326-9 · Cited by 210
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
Zhong, P., Xu, J., Yang, D., Shen, Y. L., Wang, L., Feng, Y., Du, C., Song, Y., Wu, C., Hu, X., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00373-7 · Cited by 209
Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19
Acharya, A., Agarwal, R., Baker, M. B., Baudry, J. Y., Bhowmik, D., Boehm, S., Byler, K., Chen, S., Coates, L., Cooper, C. J., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01010 · Cited by 209
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Shilts, J., Crozier, T. W. M., Greenwood, E. J. D., Lehner, P. J., & Wright, G. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-80464-1 · Cited by 209
Kulkarni, S. A., Nagarajan, S. K., Ramesh, V., Velusamy, P., Selvam, S. P., & Madhavan, T. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128823 · Cited by 208
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178
Wang, A., Chiou, J., Poirion, O., Buchanan, J., Valdez, M. J., Verheyden, J. M., Hou, X., Kudtarkar, P., Narendra, S., Newsome, J. M., et al. (2020) · eLife · doi:10.7554/elife.62522 · Cited by 207
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
Conceicao, C., Thakur, N., Human, S., Kelly, J. T., Logan, L., Bialy, D., Bhat, S., Stevenson-Leggett, P., Zagrajek, A. K., Hollinghurst, P., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001016 · Cited by 207
The SARS-CoV-2 Spike variant D614G favors an open conformational state
Mansbach, R. A., Chakraborty, S., Nguyen, K., Montefiori, D. C., Korber, B., & Gnanakaran, S. (2021) · Science Advances · doi:10.1126/sciadv.abf3671 · Cited by 206
SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
Kadam, S. B., Sukhramani, G. S., Bishnoi, P., Pable, A. A., & Barvkar, V. T. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202000537 · Cited by 206
Hatmal, M. M., Alshaer, W., Al-Hatamleh, M. A. I., Hatmal, M., Smadi, O., Taha, M. O., Oweida, A., Boer, J. C., Mohamud, R., & Plebanski, M. (2020) · Cells · doi:10.3390/cells9122638 · Cited by 205
SARS-CoV-2 Mutations and their Viral Variants
Coşar, B., KARAGÜLLEOĞLU, Z. Y., ÜNAL, S., İnce, A. T., Uncuoglu, D. B., Tuncer, G., Kilinc, B. R., Ozkan, Y. E., Ozkoc, H. C., Demir, I. N., et al. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.06.001 · Cited by 205
Isabel, S., Graña-Miraglia, L., Gutierrez, J. M., Bundalovic-Torma, C., Groves, H. E., Isabel, M. R., Eshaghi, A., Patel, S. N., Gubbay, J. B., Poutanen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70827-z · Cited by 204
Liu, H., Wu, N. C., Yuan, M., Bangaru, S., Torres, J. L., Caniels, T. G., van Schooten, J., Zhu, X., Lee, C.-C. D., Brouwer, P. J. M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.023 · Cited by 201
Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2021) · Communications Biology · doi:10.1038/s42003-021-01754-6 · Cited by 201
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Tian, D., Sun, Y., Zhou, J., & Ye, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751778 · Cited by 201
Golden, J. W., Cline, C. R., Zeng, X., Garrison, A. R., Carey, B. D., Mucker, E. M., White, L. E., Shamblin, J. D., Brocato, R. L., Liu, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142032 · Cited by 200
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
Yang, Q., Hughes, T. A., Kelkar, A., Yu, X., Cheng, K., Park, S., Huang, W., Lovell, J. F., & Neelamegham, S. (2020) · eLife · doi:10.7554/elife.61552 · Cited by 199
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
Lu, M., Uchil, P. D., Li, W., Zheng, D., Terry, D. S., Gorman, J., Shi, W., Zhang, B., Zhou, T., Ding, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.001 · Cited by 198
Idili, A., Parolo, C., Álvarez-Diduk, R., & Merkoçi, A. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01222 · Cited by 198
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Alon, R., Sportiello, M., Kozlovski, S., Kumar, A., Reilly, E. C., Zarbock, A., Garbi, N., & Topham, D. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00470-2 · Cited by 197
Amin, S. A., Banerjee, S., Ghosh, K., Gayen, S., & Jha, T. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115860 · Cited by 197
Xia, B., Shen, X.-R., He, Y., Pan, X., Liu, F., Wang, Y., Yang, F., Fang, S., Wu, Y. L., Duan, Z., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00519-4 · Cited by 197
Self-citationMolecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, J., Tao, H., Yan, Y., Huang, S., & Xiao, Y. (2020) · Viruses · doi:10.3390/v12040428 · Cited by 196
Making waves: Wastewater surveillance of SARS-CoV-2 for population-based health management
Thompson, J. R., Nancharaiah, Y. V., Gu, X., Lee, W. L., Rajal, V. B., Haines, M. B., Gironés, R., Ng, L. C., Alm, E. J., & Wuertz, S. (2020) · Water Research · doi:10.1016/j.watres.2020.116181 · Cited by 196
Yuan, S., Wang, R., Chan, J. F., Zhang, J., Cheng, T., Chik, K. K., Ye, Z., Wang, S., Lee, A. C.-Y., Jin, L., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00802-x · Cited by 196
Molecular basis of receptor binding and antibody neutralization of Omicron
Qin, H., Han, W., Li, J., Xu, S., Wang, Y., Xu, C., Li, Z., Wang, Y., Zhang, C., Huang, Z. W., et al. (2022) · Nature · doi:10.1038/s41586-022-04581-9 · Cited by 198
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
Fan, X., Cao, D., Kong, L., & Zhang, X. (2020) · Nature Communications · doi:10.1038/s41467-020-17371-6 · Cited by 195
D’Alessandro, A., Thomas, T. A., Dzieciątkowska, M., Hill, R. C., Francis, R. O., Hudson, K. E., Zimring, J. C., Hod, E. A., Spitalnik, S. L., & Hansen, K. C. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00365 · Cited by 195
Lee, J.-H., Choi, M., Jung, Y., Lee, S. K., Lee, C., Kim, J., Kim, J.-W., Kim, N. H., Kim, B., & Kim, H. G. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112715 · Cited by 195
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET
Liu, C., Mendonça, L., Yang, Y., Gao, Y., Shen, C., Liu, J., Ni, T., Ju, B., Liu, C., Tang, X., et al. (2020) · Structure · doi:10.1016/j.str.2020.10.001 · Cited by 195
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants
Laffeber, C., de Koning, K., Kanaar, R., & Lebbink, J. H. G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167058 · Cited by 194
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Essalmani, R., Jain, J., Susan‐Resiga, D., Andréo, U., Evagelidis, A., Derbali, R. M., Huynh, D. N., Dallaire, F., Laporte, M., Delpal, A., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00128-22 · Cited by 194
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Clark, S. A., Clark, L. E., Pan, J., Coscia, A., McKay, L. G. A., Shankar, S., Johnson, R. I., Brusic, V., Choudhary, M. C., Regan, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.027 · Cited by 193
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Mehdipour, A. R., & Hummer, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100425118 · Cited by 191
Alzheimer's‐like signaling in brains of COVID‐19 patients
Reiken, S. R., Sittenfeld, L. R., Dridi, H., Yang, L., Liu, X., & Marks, A. R. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12558 · Cited by 190
Chen, X., Wu, Y., Chen, C., Gu, Y., Zhu, C., Wang, S., Chen, J., Zhang, L., Lv, L., Zhang, G., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.002 · Cited by 189
Self-citationPawlowski, C., Lenehan, P. J., Puranik, A., Agarwal, V., Venkatakrishnan, A., Niesen, M. J. M., O’Horo, J. C., Virk, A., Swift, M. D., Badley, A. D., et al. (2021) · Med · doi:10.1016/j.medj.2021.06.007 · Cited by 189
Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress
Mendonça, L., Howe, A., Gilchrist, J. B., Sheng, Y., Sun, D., Knight, M. L., Zanetti-Domingues, L. C., Bateman, B. C., Krebs, A.-S., Chen, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-24887-y · Cited by 188
The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
Rajah, M. M., Bernier, A., Buchrieser, J., & Schwartz, O. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167280 · Cited by 188
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Saito, A., Tamura, T., Zahradník, J., Deguchi, S., Tabata, K., Anraku, Y., Kimura, I., Ito, J., Yamasoba, D., Nasser, H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.10.003 · Cited by 188
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
Bernard, I., Limonta, D., Mahal, L. K., & Hobman, T. C. (2020) · Viruses · doi:10.3390/v13010029 · Cited by 187
Wang, B., Zhang, L., Wang, Y., Dai, T., Qin, Z., Zhou, F., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00986-0 · Cited by 187
Self-citationWalls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.015 · Cited by 185
“SARS-CoV-2 infects host cells through the attachment of the viral transmembrane spike (S) glycoprotein to angiotensin-converting enzyme 2 (ACE2), followed by fusion of the viral and host membranes (Hoffmann et al., 2020; Lan et al., 2020; Letko et al., 2020; Shang et al., 2020; Walls et al., 2020a; Wang et al., 2020;…”
BackgroundComparative ACE2 variation and primate COVID-19 risk
Melin, A. D., Janiak, M. C., Marrone, F., Arora, P. S., & Higham, J. P. (2020) · Communications Biology · doi:10.1038/s42003-020-01370-w · Cited by 185
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
Gorkhali, R., Koirala, P., Rijal, S., Mainali, A., Baral, A., & Bhattarai, H. K. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211025876 · Cited by 185
Carpinteiro, A., Edwards, M. J., Hoffmann, M., Kochs, G., Gripp, B., Weigang, S., Adams, C., Carpinteiro, E., Gulbins, A., Keitsch, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100142 · Cited by 184
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
Yuan, M., Liu, H., Wu, N. C., & Wilson, I. A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.012 · Cited by 184
Davidson, A. M., Wysocki, J. A., & BATLLE, D. C. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15256 · Cited by 183
Metadata
- Authors
- Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X.
- Affiliations
- Tsinghua University (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zhang, Qi
- Zhang, Linqi
- Wang, Xinquan
- ORCID
- Venue
- Nature
- Published
- 2020-03-30
- Volume
- 581
- Issue
- 7807
- Pages
- 215-220
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3014067025
- Cited by
- 5,983
- References
- 38
- Citations by year
- 2026: 207 · 2025: 404 · 2024: 573 · 2023: 797 · 2022: 1237 · 2021: 1678 · 2020: 1076
- FWCI
- 152.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Salt Science Research Foundation
- Tencent
- Tsinghua University (20201080053)
- Beijing Municipal Science and Technology Commission (171100000517-001 and -003)
- Beijing Advanced Innovation Center for Structural Biology, Tsinghua University
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, spike protein, receptor binding domain, ACE2, crystal structure, SARS-CoV, convergent evolution, antibody epitopes, cross-reactive antibodies, viral entry, binding site residues
- MeSH terms
- Protein Domains, Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Amino Acid Sequence, Epitopes, Binding Sites, Humans, Hydrogen Bonding, Peptidyl-Dipeptidase A, Models, Molecular, Protein Binding, Receptors, Virus, Salts, Water, Sequence Alignment, Conserved Sequence, Crystallography, X-Ray, Evolution, Molecular, Severe acute respiratory syndrome-related coronavirus, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
